Valneva SE Files Form 6-K
Ticker: VALN · Form: 6-K · Filed: Apr 14, 2025 · CIK: 1836564
| Field | Detail |
|---|---|
| Company | Valneva Se (VALN) |
| Form Type | 6-K |
| Filed Date | Apr 14, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: reporting, foreign-private-issuer
TL;DR
Valneva SE (VLA) filed a 6-K on 4/14/25, confirming 20-F reporting. Standard disclosure.
AI Summary
Valneva SE, a biotechnology company, filed a Form 6-K on April 14, 2025. The filing indicates that the company is a foreign private issuer and will file its annual reports under Form 20-F. The company's principal executive office is located at 6 rue Alain Bombard, 44800 Saint-Herblain, France.
Why It Matters
This filing is a routine disclosure for foreign private issuers, confirming their reporting status and providing basic company information to investors.
Risk Assessment
Risk Level: low — This is a routine administrative filing for a foreign private issuer and does not contain new financial or operational information.
Key Players & Entities
- Valneva SE (company) — Filer of the Form 6-K
- 001-40377 (company) — Commission File Number
- April 14, 2025 (date) — Date of Report
- 6 rue Alain Bombard, 44800 Saint-Herblain, France (company) — Principal executive office address
FAQ
What is the purpose of a Form 6-K filing?
A Form 6-K is a report of foreign private issuers pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934, used to furnish information to the SEC that the issuer makes public in its home country.
Which form will Valneva SE use for its annual reports?
Valneva SE will file its annual reports under cover of Form 20-F.
What is Valneva SE's principal executive office address?
Valneva SE's principal executive office is located at 6 rue Alain Bombard, 44800 Saint-Herblain, France.
What is the Commission File Number for Valneva SE?
The Commission File Number for Valneva SE is 001-40377.
What is the SIC code for Valneva SE?
The Standard Industrial Classification (SIC) code for Valneva SE is 2836, which corresponds to Biological Products (no diagnostic substances).
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on April 14, 2025 regarding Valneva SE (VALN).